We are live on
!
Find out more
AA
Aufman Associates Portfolio holdings
AUM
$204M
1-Year Est. Return
39.64%
This Fund
S&P 500
This Quarter
Est. Return
+10.25%
1 Year Est. Return
+39.64%
3 Year Est. Return
+76.39%
5 Year Est. Return
+74.89%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$13.7M
(+11%)
Cap. Flow
+$2.43M
Cap. Flow
% of AUM
1.8%
Top 10 Holdings %
Top 10 Hldgs %
85.79%
Holding
54
New
8
Increased
14
Reduced
16
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$631K |
| 2 |
iShares ESG Aware MSCI EAFE ETF
ESGD
|
+$390K |
| 3 |
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
|
+$384K |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$361K |
| 5 |
iShares ESG Advanced MSCI USA ETF
USXF
|
+$265K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APLS
Apellis Pharmaceuticals
APLS
|
+$271K |
| 2 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$153K |
| 3 |
Microsoft
MSFT
|
+$113K |
| 4 |
Seagate
STX
|
+$90.5K |
| 5 |
Federated Hermes
FHI
|
+$70.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.14% |
| 2 | Healthcare | 3.5% |
| 3 | Real Estate | 3.27% |
| 4 | Financials | 2.3% |
| 5 | Communication Services | 1.78% |
Similar funds
II
CAM
KFA
OF
TBBL
WA1
TCM
RA
Aufman Associates's Q4 2021 Portfolio in Review
As of Q4 2021, Aufman Associates held 54 positions worth $135M, up 11% from $122M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Aufman Associates's Q4 2021 filing shows 8 new, 14 increased and 16 reduced positions. Its largest new stake was iShares ESG Aware MSCI EAFE ETF: 4,893 shares worth $389K. The largest sale was Apellis Pharmaceuticals, an estimated $271K.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Healthcare and Real Estate.
- Aufman Associates's largest Q4 2021 buy was iShares ESG Aware MSCI EAFE ETF: 4,893 shares worth $389K.
- Aufman Associates added most to Vanguard S&P 500 ETF in Q4 2021, an estimated $631K increase.
- Aufman Associates's biggest Q4 2021 reduction was Apellis Pharmaceuticals, cutting an estimated $271K.
- Aufman Associates's ten largest holdings make up 86% of its $135M portfolio in Q4 2021.
- Aufman Associates opened 8 new positions and closed 0 in Q4 2021.
- Aufman Associates's portfolio value rose 11% quarter-over-quarter to $135M.
Based on Aufman Associates's 13F filing for Q4 2021, filed 9 Feb 2022.